Intervet/Schering-Plough Animal Health’s Respiratory Disease Vaccine Range

Controlling respiratory disease in pigs is a difficult task. The numerous pathogens, interactions between the pathogens and different variables on individual farms make it a complicated syndrome.

Identification of the main pathogens involved on an individual farm and the selection of the appropriate vaccination program for that farm is vital for good production results. Intervet/Schering-Plough Animal Health provides vets with a technical partnership in the ever changing battle against Porcine Respiratory Disease Complex (PRDC). Skilled staff, diagnostic expertise and a full range of respiratory vaccines are available. Through the partnership of Intervet/Schering-Plough Animal Health and the pig veterinarian, pig producers can improve productivity and profits.

Vaccines to help control PRDC

• Porcilis PRRS: A PRRSV live vaccine based on an EU strain to protect against the economic losses of a PRRSV infection
• Porcilis M Hyo: An effective vaccine against M. hyopneumoniae with no interference by MDA
• M+PAC: an oil-and-water adjuvanted vaccine for control of M. hyopneumoniae in pigs
• Porcilis APP: An A. pleuropneumoniae subunit vaccine containing APXI, APXII, APXIII and OMP antigens offering broad protection
• Porcilis Glässer: The H. parasuis vaccine with proven efficacy against the most important serotypes
• Porcilis AR-T: A highly effective vaccine containing P. multocida non-toxic toxoid and B. bronchiseptica antigens.
• Porcilis PCV: An inactivated vaccine against Porcine circovirus infection developed and produced in Boxmeer, the Netherlands.

Diluvac Forte, a unique adjuvant
Diluvac Forte, a unique, patented dl-α-tocopherol (vitamin E) based formulation was specially developed for the Intervet/Schering-Plough Animal Health pig range to:

• Increase stimulation of T- and B-lymphocytes.
• Increase phagocytosis.
• Protect immune cells from critical damage by peroxidases.

By incorporating vitamin E into the adjuvant, these effects at the vaccination site result in a prolonged and enhanced immune response. Diluvac Forte is also very tissue tolerant, causing no reaction at the injection site.

Histology of muscle tissue 14 days after mineral oil adjuvant application

Histology of muscle tissue 14 days after Diluvac Forte application

The aqueous formulation means:

• Low viscosity and excellent syringeability, even at low temperatures.
• No foaming.
• Vaccination equipment is easy to clean

Diluvac Forte is thus the standard choice of adjuvant for Intervet/Schering-Plough Animal Health’s pig vaccine range.